Cas9-cleavage sequences in size-reduced plasmids enhance nonviral genome targeting of CARs in primary human T cells Journal Article


Authors: Jing, R.; Jiao, P.; Chen, J.; Meng, X.; Wu, X.; Duan, Y.; Shang, K.; Qian, L.; Huang, Y.; Liu, J.; Huang, T.; Jin, J.; Chen, W.; Zeng, X.; Yin, W.; Gao, X.; Zhou, C.; Sadelain, M.; Sun, J.
Article Title: Cas9-cleavage sequences in size-reduced plasmids enhance nonviral genome targeting of CARs in primary human T cells
Abstract: T cell genome editing holds great promise to advance a range of immunotherapies but is encumbered by the dependence on difficult-to-produce and expensive viral vectors. Here, small double-stranded plasmid DNA modified to mediate high-efficiency homologous recombination is designed. The resulting chimeric antigen receptor (CAR)-T cells display a similar phenotype, transcriptional profile, and in vivo potency to CAR-T cells generated using adeno-associated viral vector. This method should simplify and accelerate the use of precision engineering to produce edited T cells for research and clinical purposes. © 2021 Wiley-VCH GmbH
Keywords: cytology; homologous recombination; genes; clinical research; adoptive cell therapy; t-cells; antigen receptors; viral vectors; high-efficiency; cell engineering; car; crispr/cas9; precision engineering; genome targeting; nonviral methods; size-reduced plasmid; cell genome; double-stranded plasmid; nonviral; primary human t cells
Journal Title: Small Methods
Volume: 5
Issue: 7
ISSN: 2366-9608
Publisher: Wiley-VCH GmbH  
Date Published: 2021-07-15
Start Page: 2100071
Language: English
DOI: 10.1002/smtd.202100071
PROVIDER: scopus
PUBMED: 34927998
DOI/URL:
Notes: Article -- Export Date: 2 August 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michel W J Sadelain
    583 Sadelain